Wordt geladen...
STATINS AND PERCUTANEOUS CORONARY INTERVENTION. FOCUS ON THE ATORVASTATIN
The possibility of atorvastatin in reducing the risk of periprocedural myocardial infarction and other cardiovascular events in patients with percutaneous coronary intervention is discussed.
Bewaard in:
Hoofdauteur: | |
---|---|
Formaat: | Artigo |
Taal: | Inglês |
Gepubliceerd in: |
Stolichnaya Izdatelskaya Kompaniya
2015-09-01
|
Reeks: | Racionalʹnaâ Farmakoterapiâ v Kardiologii |
Onderwerpen: | |
Online toegang: | https://www.rpcardio.com/jour/article/view/192 |
Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|